Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BLKsJ-dbdb mice

This publication has 12 references indexed in Scilit:

• Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
  Diabetes Care, 1992
• Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BLKsJ-dbdb mice
  Metabolism, 1991
• Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDM
  Diabetes Care, 1991
• In vitro studies on the action of CS-045, a new antidiabetic agent
  Metabolism, 1990
• Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
  Diabetes, 1989
• HORMONAL REGULATION OF HEPATIC GLUCONEOGENESIS AND GLYCOLYSIS
  Annual Review of Biochemistry, 1988
• Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus
  The American Journal of Medicine, 1985
• [12] Phosphofructokinase from rabbit liver
  Published by Elsevier ,1975
• Further characterization of diabetes-like abnormalities in the T-KK mouse
  Diabetologia, 1974
• Abnormalities in hepatic enzyme activities during development of diabetes in db mice
  Diabetologia, 1970